Point72 (Difc) LTD Amgen Inc Call Options Transaction History

Point72 (Difc) LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $12.5 Million - $13.6 Million	-40,300 Reduced 87.61%	5,700 $1.84 Billion
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $9.91 Million - $12 Million	37,700 Added 454.22%	46,000 $14.4 Billion
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $2.23 Million - $2.69 Million	8,300 New	8,300 $2.36 Billion

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 (Difc) LTD with notifications on news.